ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 191 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,104 | -26.7% | 2,872 | +14.9% | 0.00% | – |
| Q2 2023 | $12,425 | -0.6% | 2,500 | -1.2% | 0.00% | – |
| Q1 2023 | $12,503 | -21.5% | 2,531 | 0.0% | 0.00% | – |
| Q4 2022 | $15,920 | -41.0% | 2,531 | 0.0% | 0.00% | – |
| Q3 2022 | $27,000 | -6.9% | 2,531 | 0.0% | 0.00% | – |
| Q2 2022 | $29,000 | +7.4% | 2,531 | -15.1% | 0.00% | – |
| Q1 2022 | $27,000 | -38.6% | 2,981 | +0.6% | 0.00% | – |
| Q4 2021 | $44,000 | -42.1% | 2,964 | +0.5% | 0.00% | – |
| Q3 2021 | $76,000 | -1.3% | 2,950 | -0.6% | 0.00% | – |
| Q2 2021 | $77,000 | -26.0% | 2,969 | +0.6% | 0.00% | – |
| Q1 2021 | $104,000 | +40.5% | 2,950 | 0.0% | 0.00% | – |
| Q4 2020 | $74,000 | -33.3% | 2,950 | 0.0% | 0.00% | – |
| Q3 2020 | $111,000 | +3.7% | 2,950 | +18.0% | 0.00% | – |
| Q2 2020 | $107,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
| Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
| Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
| Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
| Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
| Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
| Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
| Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
| Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |